Adrienne A Boire MD PhD

Neurology•New York, NY

Neurooncology

Associate Attending Neurologist; Associate Member, HOPP; Member, Brain Tumor Center

Request appointment

160 East 53rd StreetNew York, NY 10022
Book by Phone+1(347) 846-2860

Overview of Dr. Boire

Dr. Adrienne Boire is a neurologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Chicago Division of the Biological Sciences The Pritzker School of Medicine and has been in practice 18 years. She is one of 71 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurology. She has more than 90 publications and over 500 citings.

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 2012 - 2014
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2009 - 2012
University of ChicagoInternship, Internal Medicine, 2008 - 2009
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2008
Tufts University School of MedicinePh.D., Biochemistry, 2004

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2011 - 2028
NJ State Medical License 2022 - 2027
IL State Medical License 2008 - 2009
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

Simches Young Investigator in Neuro-Oncology Award 2017
Vienna Medical Academy Award 2017
Damon Runyon Clinical Investigator Award 2017

Clinical Trials

Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors Start of enrollment: 2020 Apr 10
COMPLETED
PHASE2

Publications & Presentations

PubMed

Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science Integration.
Yolanda Piña, Maxine Umeh Garcia, Adrienne Boire, Andrew Brenner, D Ross Camidge
Neuro-Oncology. 2026-05-27
1 citations
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases.
Monica F Chen, Jake June-Koo Lee, Noura J Choudhury, Angela B Hui, Mark Y Jeng
Journal of Thoracic Oncology. 2026-03-01
1 citations
Inflammation accelerates metastasis: Medulloblastoma leptomeningeal dissemination.
Francis Y He, Adrienne Boire
Developmental Cell. 2025-11-03

Journal Articles

Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis
Morikawa A, Jordan L, Rozner R, Patil S, Boire A, Pentsova E and AD Seidman, Clin Breast Cancer, 1/1/2016
Evaluating Cancer of the Central Nervous System through Next-Generation Sequencing of Cerebrospinal Fluid
Pentsova EI, Shah RH, Tang J, Boire A, You D, Briggs S, Omuro A, Lin X, Fleisher M, Grommes C, Meng F, Selcuklu SD, Ogilvie S, Distefano N, Shagabayeva L, Rosenblum M,..., J Clin Oncol, 1/1/2016
Molecular interactions in the development and treatment of brain metastases
Martinez NM, Boire A and LM DeAngelis, Int J Mol Sci, 1/1/2013

Lectures

Targeting carcinoma-astrocyte gap junctions in brain metastasis.
Boston, MA - 1/25/2017
Microenvironmental contributions to CNS metastasis.
Marseille, France - 1/7/2017
Complement component 3 adapts the cerebrospinal fluid for leptomeningeal metastasis.
Zurich, Switzerland - 1/5/2017

Press Mentions

MSK Research Highlights, September 25, 2025September 25th, 2025
MSK Research Highlights May 19, 2025May 19th, 2025
May 19, 2025: Key Research Breakthroughs at MSKMay 19th, 2025

Grant Support

Inflammatory Signaling in the LeptomeningesSLOAN-KETTERING INST CAN RESEARCH2025–2030
Investigating Microenvironmental Interactions in Leptomeningeal MetastasisSLOAN-KETTERING INST CAN RESEARCH2020–2025